ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000256546.1	ABT-263 (navitoclax)	Lung squamous cell carcinoma	0.042408165	Resistant
ENSG00000256546.1	ABT-263 (navitoclax)	Sarcoma	0.018033496	Resistant